Bio-Gate AG (BIG1) Fair Value & Analysis
Healthcare · DE · Market cap €6.0M
Fair value as of: Jun 24, 2026
Analysis
Bio-Gate AG (BIG1) currently trades at €0.6250, while our model-based Fair Value estimate is €0.5700 — implying the stock looks roughly 8.8% overvalued today. We read business quality at 90/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Bio-Gate AG (BIG1) undervalued?
What is the fair value of BIG1?
What is the quality score of BIG1?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.